Jeffery A. Smisek, Director at Finch Therapeutics Group, Inc. (FNCH), bought 983,190 shares at $17.00 ($1.5M) on 2021-03-23, disclosed to the SEC on 2021-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 894,955 | $0 | 0.0% |
| 2 | $17.00 | 88,235 | $1.5M | 100.0% |
| Total | $1.53 avg | 983,190 | $1.5M | 100% |
| Filing → |
| UAL | BUY | 2014-04-28 | $792K | — | Filing → |
| UAL | BUY | 2013-08-27 | $250K | — | Filing → |
| NOV | SELL | 2013-03-15 | $115K | — | Filing → |